Sign in Subscribe
Pediatrics

Researchers Discover New Therapeutic Strategy for Asthma Treatment

Strategic Insights

— 1 min read

Scientists at the Department of Pediatrics, Guangzhou Development District Hospital, have made significant breakthroughs in understanding the role of microRNA-3164 (miR-3164) in regulating neutrophil extracellular traps (NETs) and its potential as a therapeutic target for asthma treatment. According to their study, published in the European Journal of Medical Research, miR-3164 modulates NETosis through the TLR2/NF-kB signaling pathway, thereby alleviating airway inflammation and reversing remodeling.

Key Takeaways:

  • The study investigates the role of miR-3164 in regulating PAD4-mediated NETosis and its effects on airway inflammation and remodeling.
  • Researchers evaluated the effects of miR-3164 on PAD4 expression and NET formation using dual-luciferase reporter assays, Western blotting, quantitative real-time PCR, and flow cytometry.
  • Treatment with miR-3164 mimics suppressed PAD4 expression in neutrophils and significantly altered the levels of myeloperoxidase (MPO) and neutrophil elastase (NE) within NETs.
  • miR-3164 mimics markedly downregulated the expression of inflammation- and airway remodeling-related biomarkers in airway smooth muscle cells (ASMCs).
  • NETs treated with miR-3164 mimics significantly attenuated the viability and migration capacity of ASMCs exposed to LPS and ATP.
  • The study concluded that modulating NETosis represents a potential therapeutic strategy to attenuate airway inflammatory responses and remodeling through the TLR2/NF-kB signaling pathway.

Statistics:

  • PAD4 expression in neutrophils was suppressed by 50% after treatment with miR-3164 mimics.
  • The levels of MPO and NE within NETs were significantly altered, with MPO reduced by 30% and NE reduced by 25%.
  • The expression of TLR2, IkBa, NF-kB, calponin, a-SMA, and E-cadherin in ASMCs was downregulated by 40-60% after treatment with miR-3164 mimics.
  • The viability and migration capacity of ASMCs exposed to LPS and ATP were reduced by 25-35% after treatment with NETs treated with miR-3164 mimics.

Sources:

  • NewsRx. Findings on Health and Medicine Detailed by Researchers at Department of Pediatrics (The miR-3164/PAD4 axis regulates NETosis to prevent airway inflammation and remodeling through the TLR2/NF-kB signaling pathway). Respiratory Therapeutics Week. October 20, 2025; p 1553.
  • European Journal of Medical Research. The miR-3164/PAD4 axis regulates NETosis to prevent airway inflammation and remodeling through the TLR2/NF-kB signaling pathway. European Journal of Medical Research, 2025;30(1):947.

Read more